Pain Therapeutics has received a $1.8 million research grant from the National Institutes of Health (NIH) to support the…
Articles by Ana de Barros, PhD
Older people — ages 60 to 75 — in good cognitive health but with two copies of the “risk gene” for…
White women whose genes put them at risk of developing Alzheimer’s disease are more likely than white men with similar risk genes…
Vanderbilt University researchers have developed a potential therapy for Alzheimer’s disease (AD) that has shown promising results in brain…
A functional brain imaging study led by scientists at the Amen Clinics in Newport Beach, California, has qualified differences between women’s and…
Loyola Medicine will participate in a landmark $100 million study called “Imaging Dementia –…
VTv Therapeutics has received another U.S. patent for azeliragon, an Alzheimer’s treatment that targets a receptor involved in the disease’s…
The Gerontological Society of America has developed a free online toolkit to help primary-care doctors detect and diagnose cognitive…
The Alzheimer’s Research and Prevention Foundation (ARPF) will launch a new Brain Longevity Therapy Training Program to educate…
A plan to test a multi-dimensional, lifestyle-based approach to preventing cognitive decline and dementia in people at risk of Alzheimer’s…